Physician
Ultimate Priority Plus Clinic LLC
Ultimate Priority Plus Clinic LLC was paid $1.44M by Medicaid between Jan 2023 and Dec 2024, across 80 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoULTIMATE PRIORITY PLUS CLINIC LLC
DEARBORN HEIGHTS, MI 48127
DEARBORN HEIGHTS, MI 48127
33aNPI1790421253assigned 05/09/2022
33bProvider typeFamily Medicine Physician
28Total paid$1.44M
24GClaims42,952
24DCodes billed80
24AFirst – last monthJan 2023 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#94 of 826
Median peer was paid$98K
This provider vs. median15×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 19,396 | $592K | |
| 2024incomplete | 23,556 | $852K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 10,197 | 5,991 | $742K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.7% | 1,103 | 989 | $111K |
| 99490 | Ccm add 20min | 6.9% | 2,545 | 2,537 | $100K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.8% | 2,384 | 2,211 | $69K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.7% | 624 | 624 | $53K |
| 99487 | Ccm add 20min | 3.5% | 596 | 595 | $50K |
| 99426 | 3.5% | 1,278 | 1,275 | $50K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.2% | 2,357 | 2,253 | $32K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.1% | 321 | 320 | $30K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1.8% | 255 | 254 | $25K |
| 99497 | 1.7% | 521 | 520 | $24K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.6% | 1,654 | 1,564 | $23K |
68 more codes
| 99439 | 1.4% | 704 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 504 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 1,940 | $17K |
| 99385 | 1.0% | 134 | $15K | |
| 99386 | <1% | 83 | $11K | |
| 96156 | <1% | 207 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,322 | $6K |
| 99407 | <1% | 417 | $6K | |
| 20553 | <1% | 115 | $4K | |
| 99442 | <1% | 54 | $4K | |
| 99406 | <1% | 411 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 29 | $3K |
| 96127 | <1% | 920 | $3K | |
| 29530 | <1% | 124 | $2K | |
| 81003 | <1% | 1,108 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 341 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,059 | $2K |
| 29540 | <1% | 93 | $1K | |
| 80305 | <1% | 132 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 517 | $725.74 |
| 90688 | <1% | 30 | $590.07 | |
| 99473 | <1% | 74 | $585.04 | |
| 29125 | <1% | 13 | $533.44 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 32 | $520.35 |
| 69209 | <1% | 31 | $382.01 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 16 | $354.68 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 18 | $341.94 |
| 29130 | <1% | 12 | $326.38 | |
| 90658 | <1% | 27 | $314.80 | |
| 93000 | <1% | 34 | $283.48 | |
| 82962 | <1% | 59 | $154.24 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 32 | $146.84 |
| 81025 | <1% | 19 | $137.75 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 16 | $118.89 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 388 | $96.33 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 84 | $56.92 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 18 | $48.15 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 153 | $2.94 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 28 | $2.80 |
| 3074F | <1% | 789 | $1.44 | |
| 3078F | <1% | 665 | $1.19 | |
| S9449 | Weight management classes, non-physician provider, per session | <1% | 174 | $0.47 |
| 3079F | <1% | 196 | $0.34 | |
| 1034F | <1% | 186 | $0.28 | |
| S9452 | Nutrition classes, non-physician provider, per session | <1% | 115 | $0.26 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 418 | $0.23 |
| 3075F | <1% | 127 | $0.23 | |
| 3048F | <1% | 137 | $0.23 | |
| S9451 | Exercise classes, non-physician provider, per session | <1% | 54 | $0.16 |
| 3080F | <1% | 61 | $0.08 | |
| 3049F | <1% | 32 | $0.06 | |
| 3077F | <1% | 31 | $0.04 | |
| 3050F | <1% | 12 | $0.03 | |
| 3044F | <1% | 480 | $0.03 | |
| 1160F | <1% | 191 | $0.01 | |
| 1159F | <1% | 230 | $0.01 | |
| 3725F | 0% | 1,002 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 291 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 503 | $0.00 |
| 3288F | 0% | 33 | $0.00 | |
| 2000F | 0% | 955 | $0.00 | |
| 1125F | 0% | 32 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 167 | $0.00 |
| 1036F | 0% | 309 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 395 | $0.00 |
| 97802 | 0% | 136 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 53 | $0.00 |
| 1170F | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMZE, ABBASS (PRESIDENT)